Simone Del Sarto

Dr. Simone Del Sarto

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
MPMichele PsyD Poletti
Michele PsyD Poletti
CLChiara Logi
Chiara Logi
CLClaudio Lucetti
Claudio Lucetti
PDPaolo Del Dotto
Paolo Del Dotto
FBFilippo Baldacci
Filippo Baldacci
UBUbaldo Bonuccelli
Ubaldo Bonuccelli
The current study aimed at establishing the prevalence of impulse control disorders (ICDs) in patients with Parkinson disease (PD) and their association with demographic, drug-related, and disease-related characteristics. We performed a single-center cross-sectional study of 805 PD patients. Impulse control disorders were investigated with the Questionnaire for Impulsive Compulsive Disorders in Parkinson’s Disease; also comorbid neuropsychiatric complications (dementia, delusions, visual hallucinations) were investigated with clinical interviews and ad hoc instruments (Parkinson Psychosis Questionnaire and Neuropsychiatry Inventory). Impulse control disorders were identified in 65 patients (prevalence, 8.1%), with pathological gambling and hypersexuality the most frequent. Impulse control disorders were present in 57 of 593 cognitively preserved patients (prevalence, 9.6%) and in 8 of 212 demented patients (prevalence, 3.8%). Impulse control disorders were significantly associated with dopamine agonists (odds ratio [OR], 5.50; 95% confidence interval [CI], 2.60–12.46; P < 0.0001) and levodopa (OR, 2.43; 95% CI, 1.06–6.35; P = 0.034). Impulse control disorders frequency was similar for pramipexole and ropinirole (16.6% vs 12.5%; OR, 1.45; 95% CI, 0.79–2.74; P = 0.227). Additional variables associated with ICDs were male sex and younger age. These findings suggested that dopaminergic treatments in PD are associated with increased odds of having an ICD, but also other demographic and clinical variables are associated with ICDs, suggesting the multifactorial nature of the ICD phenomenon in PD.

1 March 2013 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
LMLuca Manetti
Luca Manetti
GRGiuseppe Rossi
Giuseppe Rossi
LGLucia Grasso
Lucia Grasso
VRValentina Raffaelli
Valentina Raffaelli
ISIlaria Scattina
Ilaria Scattina
EMEnio Martino
Enio Martino
Objective: Several tests have been proposed to diagnose patients with Cushing's syndrome (CS). The aims of the study were: i) to evaluate the performance of salivary cortisol (SC) in hypercortisolism and ii) to compare SC with serum cortisol (SeC) and urinary cortisol.Design and patients: This was a diagnostic study. Twenty-seven patients with untreated Cushing's disease (CD untr), 21 women consuming oral contraceptive pill (OCP), 18 pregnant women, and 89 healthy subjects (controls) were enrolled.Methods: SC and SeC at baseline and after the low-dose dexamethasone suppression test (LDDST) and urinary free cortisol (UFC) were measured.Results: Midnight SC had a sensitivity of 100% in the CD untr group and a specificity of 97.7% in the controls. Specificity remained high (95.2%) in women taking OCP, while in pregnant women, it decreased to 83.3%. SC after the LDDST showed a sensitivity of 96.3% in the CD untr group; specificity was 97.7% in the controls and 90.5% in OCP women. Midnight SeC had a sensitivity of 100% in the CD untr group. SeC after the LDDST had a sensitivity of 100% in the CD untr group while specificity was 97.7% in the controls and 61.9% in women taking OCP. For UFC, sensitivity was 92.6% in the CD untr group while specificity was 97.7% in the controls and 100% in the OCP group.Conclusions: SC is a reliable parameter for the diagnosis of severe hypercortisolism, with high sensitivity and specificity. In women during pregnancy or taking OCP, the measurement of SC, identifying the free fraction, could be helpful to exclude CS.

1 September 2013 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
FBFausto Bogazzi
Fausto Bogazzi
ACAnnamaria Colao
Annamaria Colao
GRGiuseppe Rossi
Giuseppe Rossi
MLMartina Lombardi
Martina Lombardi
CUClaudio Urbani
Claudio Urbani
EMEnio Martino
Enio Martino
Objective: Acromegalic patients have an increased risk of mortality. The objective of this study was to compare the effect of different therapies for acromegaly on mortality.Design and methods: The mortality rate of 438 consecutive acromegalic patients was compared with that of the general population using the standardized mortality ratio (SMR); the effect of different therapies on survival was evaluated using Cox regression analysis.Results: Twenty patients (4.5%) died between 1999 and 2009. Age- and sex-adjusted SMR was 0.70 (95% CI 0.43–1.08). The Cox regression analysis revealed that, in the whole population, both general risk factors (age and physical status) and specific factors for acromegaly (macroadenoma, hypopituitarism and uncontrolled disease) were associated with death. The most compromised patients at diagnosis had a higher mortality rate (P=0.001), which also occurred in patients with controlled acromegaly. Death occurred in 2.4% (adenomectomy), 2.6% (adenomectomy followed by somatostatin analogue (SSA) therapy) and 11.4% (SSA therapy as the primary therapy) of the patients. The risk of death was higher in patients receiving SSA therapy as the primary therapy (hazard ratio (HR) 5.52, 95% CI 1.06–28.77,P=0.043) than in all patients submitted to adenomectomy; however, a higher risk of death occurred only in diabetic patients treated with SSAs alone (HR 21.94, 95% CI 1.56–309.04,P=0.022). Radiotherapy was associated with an increased risk of mortality, which occurred in patients with the more locally advanced disease.Conclusions: Therapies for acromegaly and comorbidities have lowered the risk of mortality to the level of the general population; the effect of SSA therapy alone or that following pituitary adenomectomy was comparable to that of curative neurosurgery on survival in non-diabetic patients; on the contrary, SSA therapy as the primary therapy may be less effective than adenomectomy in reducing mortality rate in diabetic patients.

5 May 2014 in Clinical Endocrinology
Verified
Journal Article
Closed access
CSChiara Sardella
Chiara Sardella
CUClaudio Urbani
Claudio Urbani
MLMartina Lombardi
Martina Lombardi
ANAlessandro Nuzzo
Alessandro Nuzzo
LMLuca Manetti
Luca Manetti
FBFausto Bogazzi
Fausto Bogazzi

29 March 2024 in Social Indicators Research
Verified
Journal Article
Open access
PDF file
MGMichela Gnaldi
Michela Gnaldi
SSSimone Del Sarto
Simone Del Sarto
Times of crisis provide fertile ground for corruption because of looser regulatory frameworks, weaker oversight, and skyrocketing financing levels. Public procurement systems are particularly vulnerable to corruption risks over emergency periods as they are at the frontline of many country responses to crises. In this paper, we propose a curated selection of red flag indicators of corruption risk over crises and discuss a general measurement framework for their computation. The proposed approach exploits the time discontinuity introduced by a crisis and allows us to characterise and differentiate companies and/or contracting authorities with different degree of risk through statistical testing. The suggested framework is intended to accommodate the changing and far-reaching corruption risks induced by crises and mitigate them effectively.

30 October 2023 in Social Indicators Research
Verified
Journal Article
Open access
PDF file
MGMichela Gnaldi
Michela Gnaldi
SSSimone Del Sarto
Simone Del Sarto
The Agenda 2030 recognises corruption as a major obstacle to sustainable development and integrates its reduction among SDG targets, in view of developing peaceful, just and strong institutions. In this paper, we propose a method to assess the validity of corruption indicators within an Item Response Theory framework, which explicitly accounts for the latent and multidimensional facet of corruption. Towards this main aim, a set of fifteen red flag indicators of corruption risk in public procurement is computed on data included in the Italian National Database of Public Contracts. Results show a multidimensional structure composed of sub-groups of red flag indicators i. measuring distinct corruption risk categories, which differ in nature, type and entity, and are generally non-superimposable; ii. mirroring distinct dynamics related to specific SDG principles and targets.